News | May 31, 2021
Margins impacted by high expenses for Pfizer: ICICI Securities
Adjusted PAT declined 18.8% YoY
Adjusted PAT declined 18.8% YoY
Revenue from operations for the year ended March 31, 2021 is ?2,239 crore
The company has posted net profit of Rs.397.06 crores for the 9 months period ended December 31, 2020.
The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
Benzonatate is a non-narcotic antitussive that numbs stretch receptors in the respiratory tract
Capital infusion to accelerate Earendil’s R&D platform
Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
India in the Changing Landscape of Life-Sciences Research & Development
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
